Tourmaline Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tourmaline Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Tourmaline Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$20.2M, a 261% decline year-over-year.
  • Tourmaline Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$63.9M, a 1091% decline year-over-year.
  • Tourmaline Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$42.1M, a 114% decline from 2022.
  • Tourmaline Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.7M, a 58.8% increase from 2021.
  • Tourmaline Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$47.8M, a 111% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$63.9M -$20.2M -$14.6M -261% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$49.3M -$17.5M -$1.36M -8.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$47.9M -$13.3M -$5.81M -77.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$42.1M -$12.9M -$48.6M -136% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $6.44M -$5.59M +$13.4M +70.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$6.98M -$16.1M +$1.97M +10.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$8.94M -$7.5M +$10.8M +58.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$19.7M $35.7M +$49.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$69.6M -$19M -$6.07M -46.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$63.5M -$18.1M -$6.74M -59.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$56.8M -$18.3M -$8.96M -96.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$47.8M -$14.2M -$7.46M -110% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$40.4M -$12.9M -$6.52M -102% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$33.8M -$11.4M -$6.69M -143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$27.2M -$9.3M -$4.45M -91.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$22.7M -$6.78M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$6.42M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.66M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$4.85M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.